This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Albert Einstein College of Medicine. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Claudia Gravekamp: Innovator in Cancer Treatment
Introduction
Claudia Gravekamp is a prominent inventor based in New York, NY (US), known for her significant contributions to cancer treatment through innovative research. With a total of 3 patents, she has made remarkable strides in the field of oncology.
Latest Patents
Her latest patents include groundbreaking methods and compositions for cancer treatment. One of her notable inventions is the "Treatment of cancer using recall antigens delivered by attenuated bacteria," which discloses methods, pharmaceutical compositions, and vaccines that utilize attenuated bacteria expressing recall antigens for effective cancer therapy. Another significant patent is "Radiobacteria for therapy of cancer," which provides a method for treating tumors or preventing metastasis by administering bacteria labeled with radionuclides. This innovative approach aims to enhance the efficacy of cancer treatments.
Career Highlights
Claudia Gravekamp is affiliated with the Albert Einstein College of Medicine, where she conducts her research and develops her inventions. Her work has been instrumental in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes.
Collaborations
She collaborates with esteemed colleagues, including Ekaterina Dadachova and Arturo Casadevall, who contribute to her research efforts and enhance the impact of her work in the field of cancer therapy.
Conclusion
Claudia Gravekamp's innovative contributions to cancer treatment through her patents and research exemplify her commitment to advancing medical science. Her work continues to inspire and pave the way for future breakthroughs in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
